Millennium Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-357,411
Closed -$194K – 4069
2016
Q3
$194K Sell
357,411
-102,917
-22% -$47.1K ﹤0.01% 2993
2016
Q2
$268K Buy
+460,328
New +$491K ﹤0.01% 2786
2016
Q1
– Sell
-24,391
Closed -$78K – 4035
2015
Q4
$78K Sell
24,391
-1,909
-7% -$9.18K ﹤0.01% 3273
2015
Q3
$164K Buy
26,300
+13,176
+100% +$123K ﹤0.01% 3175
2015
Q2
$130K Buy
+13,124
New +$115K ﹤0.01% 3128
2014
Q2
– Sell
-17,418
Closed -$126K – 4315
2014
Q1
$126K Buy
+17,418
New +$103K ﹤0.01% 3274

Other funds holding NWBO

Millennium Management's NWBO Position: Q4 2016 in Review

Millennium Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 357,411 shares — an estimated $194K sold.

Millennium Management first reported a position in NWBO in Q1 2014 and held it in 6 quarters. The position peaked at $268K in Q2 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Millennium Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Millennium Management sold 357,411 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $194K.
  • Millennium Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 6 quarters.
  • Millennium Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $268K in Q2 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.